Barclays’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$416K Buy
338,792
+93,692
+38% +$115K ﹤0.01% 3133
2025
Q1
$270K Buy
245,100
+245,000
+245,000% +$270K ﹤0.01% 3180
2024
Q4
$0 Sell
100
-20,964
-100% ﹤0.01% 4405
2024
Q3
$21K Sell
21,064
-748,564
-97% -$746K ﹤0.01% 4058
2024
Q2
$693K Buy
769,628
+769,528
+769,528% +$693K ﹤0.01% 2322
2024
Q1
$0 Hold
100
﹤0.01% 4203
2023
Q4
$0 Sell
100
-100
-50% ﹤0.01% 4254
2023
Q3
$0 Buy
200
+99
+98% ﹤0.01% 4304
2023
Q2
$0 Sell
101
-41,479
-100% ﹤0.01% 4300
2023
Q1
$52K Sell
41,580
-1,391,040
-97% -$1.74M ﹤0.01% 3777
2022
Q4
$3.11M Buy
1,432,620
+1,279,971
+839% +$2.78M ﹤0.01% 1383
2022
Q3
$1.83M Buy
152,649
+147,670
+2,966% +$1.77M ﹤0.01% 1717
2022
Q2
$41K Buy
+4,979
New +$41K ﹤0.01% 3803
2022
Q1
Sell
-72,450
Closed -$819K 4794
2021
Q4
$819K Buy
+72,450
New +$819K ﹤0.01% 2306
2021
Q3
Sell
-13,429
Closed -$109K 4017
2021
Q2
$109K Buy
13,429
+12,942
+2,657% +$105K ﹤0.01% 3113
2021
Q1
$5K Sell
487
-27,234
-98% -$280K ﹤0.01% 3755
2020
Q4
$268K Buy
+27,721
New +$268K ﹤0.01% 2579
2020
Q3
Sell
-52,714
Closed -$685K 3792
2020
Q2
$685K Buy
52,714
+51,745
+5,340% +$672K ﹤0.01% 2144
2020
Q1
$10K Buy
969
+960
+10,667% +$9.91K ﹤0.01% 3483
2019
Q4
$0 Sell
9
-86,188
-100% ﹤0.01% 3998
2019
Q3
$1.45M Buy
+86,197
New +$1.45M ﹤0.01% 2016
2019
Q2
Sell
-3,138
Closed -$68K 4294
2019
Q1
$68K Buy
+3,138
New +$68K ﹤0.01% 3522